C. Fagnère

发表

Design, synthesis and evaluation of 4-imidazolylflavans as new leads for aromatase inhibition.

C. Pouget, C. Fagnère, J. Basly, 2002, Bioorganic & medicinal chemistry letters.

2′-Hydroxy-4-methylsulfonylchalcone enhances TRAIL-induced apoptosis in prostate cancer cells

B. Liagre, J. Beneytout, M. Diab-Assaf, 2015, Anti-cancer drugs.

Impact of new cyclooxygenase 2 inhibitors on human cytomegalovirus replication in vitro

B. Liagre, C. Pouget, S. Hantz, 2021, Antiviral therapy.

synthetic strategies to 2'-hydroxy-4'-methylsulfonylacetophenone, a key compound for the preparation of flavonoid derivatives

C. Pouget, J. Duroux, C. Fagnère, 2014 .

Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors.

C. Pouget, C. Fagnère, A. Chulia, 2011, European journal of medicinal chemistry.

New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation.

C. Pouget, C. Fagnère, A. Chulia, 2008, Bioorganic & medicinal chemistry.

Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors.

C. Pouget, C. Fagnère, G. Habrioux, 2004, Bioorganic & medicinal chemistry letters.

Resistance to 3‐HTMC‐Induced Apoptosis Through Activation of PI3K/Akt, MEK/ERK, and p38/COX‐2/PGE2 Pathways in Human HT‐29 and HCT116 Colorectal Cancer Cells

B. Liagre, V. Sol, C. Pouget, 2016, Journal of cellular biochemistry.

Enhancement of hydrosolubility and in vitro antiproliferative properties of chalcones following encapsulation into β-cyclodextrin/cellulose-nanocrystal complexes.

B. Liagre, R. Granet, V. Sol, 2019, Bioorganic & medicinal chemistry letters.

Flavonoids: structural requirements for antiproliferative activity on breast cancer cells.

C. Pouget, C. Delage, A. Simon, 2001, Bioorganic & medicinal chemistry letters.

New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-substituted flavanone derivatives.

C. Pouget, C. Fagnère, J. Basly, 2002, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluation of chalcone-polyamine conjugates as novel vectorized agents in colorectal and prostate cancer chemotherapy.

B. Liagre, V. Sol, C. Pouget, 2021, European journal of medicinal chemistry.

A theoretical study of the conformational behavior and electronic structure of taxifolin correlated with the free radical-scavenging activity

R. Lazzaroni, P. Trouillas, J. Duroux, 2004 .

Novel methylsulfonyl chalcones as potential antiproliferative drugs for human prostate cancer: involvement of the intrinsic pathway of apoptosis.

B. Liagre, J. Beneytout, C. Pouget, 2013, International journal of oncology.

Reactivity of Chalcones with 1-Hydroxymethyl Radicals

P. Trouillas, J. Duroux, C. Fagnère, 2006, Radiation research.

Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors.

C. Pouget, C. Fagnère, G. Habrioux, 2004, Bioorganic chemistry.

Chalcones are potent inhibitors of aromatase and 17β-hydroxysteroid dehydrogenase activities

C. Pouget, J. Le Bail, J C Le Bail, 2001 .

Contributions of a blended learning based on peer evaluation for teaching drug-drug interactions to undergraduate pharmacy students

N. Picard, C. Pouget, M. Laroche, 2019, BMC Medical Education.

Synthesis and Aromatase Inhibitory Activity of Flavanones

C. Pouget, C. Fagnère, J. Basly, 2002, Pharmaceutical Research.

Synthesis and Structure of Flavan-4-ols and 4-Methoxyflavans as New Potential Anticancer Drugs

C. Pouget, C. Fagnère, J. Basly, 2000 .

2′-Hydroxy-4-methylsulfonylchalcone enhances TRAIL-induced apoptosis in prostate cancer cells

B. Liagre, J. Beneytout, C. Pouget, 2015, Anti-cancer drugs.

Contributions of a blended learning based on peer evaluation for teaching drug-drug interactions to undergraduate pharmacy students

N. Picard, C. Pouget, M. Laroche, 2019, BMC Medical Education.